Nazanin Bashiri

TENSION – Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window: a Randomized, Controlled Trial. Start year: 2018

TENSION Official title: Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window: a Randomized, Controlled Trial Trial start year: 2018 Trial websitewww.tension-study.comView website Trial registrationNCT03094715View registration Design paper2018A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time windowDownload full paper Result …

TENSION – Efficacy and Safety of Thrombectomy in Stroke With Extended Lesion and Extended Time Window: a Randomized, Controlled Trial. Start year: 2018 Read More »

TECTO – Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive Disorder. Start year: 2018

TECTO Official title: Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive DisorderTrial start year: 2018 Trial websiteNo website available Trial registrationNCT03595098View registration Design paperNo design paper published Result paperNo result paper published

MBT-Trial – Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical Trial. Start year: 2018

MBT-Trial Official title: Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical TrialTrial start year: 2018 Trial websiteNo website available Trial registrationNCT03677037View registration Design paper2019Short-term versus long-term mentalizationbased therapy for outpatients with subthreshold or diagnosed borderline personality disorder: a protocol for a randomized clinical trialDownload full paper …

MBT-Trial – Short-term Versus Long-term Mentalization-based Therapy for Outpatients With Subthreshold or Diagnosed Borderline Personality Disorder: a Randomized Clinical Trial. Start year: 2018 Read More »

VIXIE – Hyperoxia and antioxidants during major non-cardiac surgery and risk of cardiovascular complications, a blinded 2×2 factorial randomised clinical trial. Start year: 2018

VIXIE Official title: Hyperoxia and Antioxidants During Major Non-cardiac Surgery and Risk of Cardiovascular Complications, a Blinded 2×2 Factorial Randomised Clinical TrialTrial start year: 2018 Trial websiteNo website available Trial registrationNCT03494387View registration Design paper2019Hyperoxia and antioxidants during major non-cardiac surgery and risk of cardiovascular events: Protocol for a 2 × 2 factorial randomised clinical trialDownload …

VIXIE – Hyperoxia and antioxidants during major non-cardiac surgery and risk of cardiovascular complications, a blinded 2×2 factorial randomised clinical trial. Start year: 2018 Read More »

AID-ICU – Agents Intervening Against Delirium in Intensive Care Unit (AID-ICU) A Randomized, Blinded, Placebo-controlled Trial. Start year: 2018

AID-ICU Official title: Agents Intervening Against Delirium in Intensive Care Unit (AID-ICU) A Randomized, Blinded, Placebo-controlled TrialTrial start year: 2018 Trial websitewww.cric.nu/aid-icu-trialView website Trial registrationNCT03392376View registration Design paper2019Agents intervening against delirium in the intensive care unit (AID‐ICU) – Protocol for a randomised placebo‐controlled trial of haloperidol in patients with delirium in the ICUDownload full paper …

AID-ICU – Agents Intervening Against Delirium in Intensive Care Unit (AID-ICU) A Randomized, Blinded, Placebo-controlled Trial. Start year: 2018 Read More »

MACUSTAR – Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD). Start year: 2018

MACUSTAR Official title: Development of novel clinical endpoints for interventional clinical trials with a regulatory and patient access intention in patients with intermediate age-related macular degeneration (AMD)Trial start year: 2018 Trial websitewww.macustar.euView website Trial registrationNCT03349801View registration Design paper2020Clinical study protocol for a lowinterventional study in intermediate agerelated macular degeneration developing novel clinical endpoints for interventional …

MACUSTAR – Development of Novel Clinical Endpoints for Interventional Clinical Trials With a Regulatory and Patient Access Intention in Patients With Intermediate Age-related Macular Degeneration (AMD). Start year: 2018 Read More »